| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1994) |
| Entry Type: | Enzyme |
| Molecule Category: | UNKNOWN |
| ATC: | L01XX24 |
| UNII: | 7D96IR0PPM |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| HYDROLYTIC ENZYME | Asparagine hydrolytic enzyme | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | D054198 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | D054198 | ClinicalTrials |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | D054198 | ClinicalTrials |
| Lymphoma | 3 | D008223 | ClinicalTrials |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054218 | ClinicalTrials |
| Lymphohistiocytosis, Hemophagocytic | 3 | D051359 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 3 | D015456 | ClinicalTrials |
| Granuloma, Lethal Midline | 3 | D006103 | ClinicalTrials |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | D054218 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 3 | D015456 | ClinicalTrials |
| Leukemia, Biphenotypic, Acute | 3 | D015456 | ClinicalTrials |
| Leukemia | 3 | D007938 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 130167-69-0 |
| ChEMBL | CHEMBL2108546 |
| FDA SRS | 7D96IR0PPM |
CONTENTS